The shelf is a potential dilutive overhang, but the I.B.6 one-third rule severely limits any primary offering size. The company's financial distress and going-concern warning make any capital raise a necessity, not a growth opportunity. Monitor for any prospectus supplement that would specify the actual offering terms and size.
Price Chart
Executive Summary
Niki BioSolutions (NIKI) filed Pre-Effective Amendment No. 3 to its S-3 shelf registration, updating disclosure on Hong Kong operational risks per SEC comments, and registering up to $75M in securities. The shelf is a routine administrative step, but the filing reveals a distressed financial position: the company has a going-concern warning from its auditor, negative working capital of -$1.0M, and a $73.8M accumulated deficit as of Dec 2025. The shelf provides a potential dilutive capital raise, but the company's tiny $5M public float and I.B.6 one-third limit constrain the size of any primary offering. The filing is bearish due to the company's fundamental financial distress and the overhang of potential dilution.
Key Financial Metrics
Key Facts
- S-3 shelf registering up to $75,000,000 in securities (common, preferred, warrants, rights, debt, units) for potential future offerings.
- As of Sep 30, 2026, public float was only $5,008,895.46 (1,056,729 shares at $4.72), limiting any primary offering to ~$1.67M under I.B.6 one-third rule.
- Auditor's audit report includes a going-concern paragraph for the company (Marcum Asia CPAs LLP report dated Mar 27, 2026).
- Negative working capital of $1,001,299 and net operating cash outflow of $1,836,546 for FY2025.
- Accumulated deficit of $73,792,798 as of Dec 31, 2025.
- Net loss of $1,363,270 for FY2025.
- 2,060,180 warrants outstanding as of Dec 31, 2025, with weighted-average exercise price of $2.01.
- DiamiR subsidiary also has a going-concern warning from its auditor (CBIZ CPAs P.C. report dated Aug 21, 2026).
- DiamiR has never generated revenue from product sales and is pre-commercial stage.
- Convertible note of $3,418,500 due to related party (Jurchen Investment Corp) as of Dec 31, 2025.
Financial Impact
The shelf allows for up to $75M in potential future dilution, but the I.B.6 rule caps any primary offering to ~$1.67M due to the $5M public float. The company's financial distress is severe: $1.0M negative working capital, $73.8M deficit, and $1.36M net loss in FY2025.
Risk Factors
- Potential future dilution from shelf offerings.
- Going-concern risk: auditor has expressed substantial doubt about ability to continue as a going concern.
- Negative working capital and operating cash flow.
- Large accumulated deficit.
- DiamiR subsidiary also has a going-concern warning and no product revenue.
- Hong Kong operational and PRC regulatory risks.
- Delisting risk: company has a history of non-compliance with Nasdaq minimum bid price.
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| S-3/A Filing (Primary) | 0001213900-26-106480 |
| Document: ea030711701ex23-1.htm | 0001213900-26-106480 |
| Document: ea030711701ex23-2.htm | 0001213900-26-106480 |
| Document: 0001213900-26-106480-index-headers.html | 0001213900-26-106480 |
| Document: 0001213900-26-106480-index.html | 0001213900-26-106480 |
| Document: 0001213900-26-106480.txt | 0001213900-26-106480 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 13, 2026 13d ago | EFFECT | $2.63 $2.03 | ▲ +22.67% | ▲ +21.52% | $1.91 (+27.24%) |
Oct 2, 2026 23d ago | S-3/A | $4.73 $3.02 | ▲ +36.13% | ▲ +36.55% | $1.91 (+59.61%) |
Sep 25, 2026 4w ago | Press Release | $4.76 $4.60 | ▼ −3.36% | ▼ −3.14% | $1.91 (−59.87%) |
Sep 18, 2026 5w ago | S-3/A | $4.97 $4.70 | ▲ +5.43% | ▲ +4.41% | $1.91 (+61.57%) |
Aug 27, 2026 8w ago | S-3 | $6.90 $6.20 | ▲ +10.14% | ▲ +10.25% | $1.91 (+72.32%) |
Aug 7, 2026 11w ago | 8-K | $8.62 $8.26 | ▼ −4.18% | ▼ −4.13% | $1.91 (−77.84%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers